During the past decade, Mission Hospitals Inc conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 9 clinical trials were completed, i.e. on average, 81.8% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 3 clinical trials were completed. i.e. 42.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mission Hospitals Inc" #1 sponsor was "Abbott Medical Devices" with 7 trials, followed by "Children's Oncology Group" with 7 trials sponsored, "Bolton Medical" with 1 trials sponsored, "Canadian Cancer Trials Group" with 1 trials sponsored and "Debiovision" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mission Hospitals Inc" #1 collaborator was "National Cancer Institute (NCI)" with 8 trials as a collaborator, "Chiesi Farmaceutici S.p.A." with 1 trials as a collaborator, "Daiichi Sankyo, Inc." with 1 trials as a collaborator, "ETOP IBCSG Partners Foundation" with 1 trials as a collaborator and "East Carolina University" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Mission Hospitals Inc" are "Stroke" (2 trials), "Abdominal Aortic Aneurysm" (1 trials), "Acute Stroke" (1 trials), "Adenocarcinoma of the Colon" (1 trials) and "Adrenocortical Carcinoma" (1 trials). Many other conditions were trialed in "Mission Hospitals Inc" in a lesser frequency.

Most popular intervention types in "Mission Hospitals Inc" are "Device" (9 trials), "Drug" (9 trials), "Biological" (5 trials), "Other" (5 trials) and "Procedure" (5 trials). Other intervention types were less common.

The name of intervention was led by "conventional surgery" (3 trials), "cyclophosphamide" (3 trials), "doxorubicin hydrochloride" (3 trials), "etoposide" (3 trials) and "3-dimensional conformal radiation therapy" (2 trials). Other intervention names were less common.

The vast majority of trials in "Mission Hospitals Inc" are 22 trials for "All" genders.

Currently, there are NaN active trials in "Mission Hospitals Inc". undefined are not yet recruiting, 5 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Mission Hospitals Inc, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mission Hospitals Inc, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 8 trials that are defined as “Not Applicable".

Mission Hospitals Inc has several departments that took part in Clinical trials: "Asheville Cardiology Associates" - 40 trials, "Mountain Radiation Oncology PA" - 12 trials, "Mission Hospital Research Institute" - 2 trials